TLR3 and colorectal carcinoma: Furthermore, another study has reported that TLR3, 4, and 7 expression in primary CRC cells and immune cells enabled targeting with combined agonists, activating immune-cell- directed killing of CRC cells in coculturing assays (Stier et al., 2013).